This study is not yet accepting patients
First in Human Study of UCT-01-097 in Participants With Advanced Solid Tumors
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Location
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- 1200 Pharma, LLC
- ID
- NCT04761601
- Phase
- Phase 1
- Study Type
- Interventional
- Last Updated